tevabehist 16 mg tablets
Тева Фармасютикълс България ЕООД - Бетагистина - 16 mg tablets
tevabehist 24 mg tablets
Тева Фармасютикълс България ЕООД - Бетагистина - 24 mg tablets
betaserc 16 mg tablets
bgp products b.v. - Бетагистина - 16 mg tablets
betaserc 24 mg orodispersible tablets
abbott arzneimittel gmbh - Бетагистина - 24 mg orodispersible tablets
vestibo 16 mg tablets
Актавис ЕАД - Бетагистина - 16 mg tablets
vestibo 24 mg tablets
Актавис ЕАД - Бетагистина - 24 mg tablets
vestibo 8 mg tablets
Актавис ЕАД - Бетагистина - 8 mg tablets
betaserc 24 mg tablets
mylan healthcare gmbh - Бетагистина - 24 mg tablets
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - Туберкулоза, мултирезистентни - Антимикобактериални - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). Трябва да се вземат предвид официалните препоръки за правилното използване на антибактериални агенти.